Kyorin Pharmaceutical Co Ltd TSE:4569:
KYORIN PHARMACEUTICAL CO LTD: KYORIN ENTERS INTO LICENSE AGREEMENT WITH BIODOL FOR NOVEL NEUROPATHIC PAIN TREATMENT
Kyorin Pharmaceutical Co Ltd - Kyorin Enters Into License Agreement With Biodol For Novel Neuropathic Pain Treatment
Earlier from Kyorin Pharmaceutical Co.,ltd
- TABLE-Kyorin Pharmaceutical - 9-MTH group results
- KYORIN Pharmaceutical: Strong nine-month results, but full-year outlook projects lower sales and profits
- KYORIN Pharmaceutical: Net sales rose 6.5% YoY, but operating profit fell on higher R&D; guidance unchanged
- Kyorin Pharmaceutical Co Ltd - Kyorin And Hinge Bio Enter Into A Collaboration And License Agreement Of Hb2198 In Japan For Sle And Other Diseases